Valuing gene testing in children with possible neurofibromatosis 1
E Tsang1, P Birch, J M Friedman
1Department of Medical Genetics, University of British Columbia, Vancouver, Canada. ertsang@interchange.ubc.ca
Clinical Genetics
|October 22, 2011
Summary
Genetic testing for neurofibromatosis 1 (NF1) offers good economic value for children with possible NF1. Early diagnosis through genetic testing provides significant benefits to patients and the healthcare system.
Area of Science:
- Medical Genetics
- Health Economics
- Clinical Diagnostics
Background:
- Clinical guidelines increasingly recommend genetic testing.
- Neurofibromatosis 1 (NF1) diagnosis relies on clinical criteria, but genetic testing offers higher accuracy.
- Children with 'possible NF1' incur healthcare costs due to ongoing monitoring.
Purpose of the Study:
- To evaluate the economic value of genetic testing for children with possible NF1 in British Columbia.
- To compare the costs of current NF1 diagnostic protocols with a strategy incorporating genetic testing.
- To understand the qualitative benefits of early diagnosis via genetic testing.
Main Methods:
- Economic modeling to assess healthcare system costs.
- Comparison of current clinical follow-up protocols versus genetic testing for possible NF1.
- Analysis of incremental costs associated with genetic testing.
Main Results:
- Genetic testing for possible NF1 provides good economic value.
- Molecular diagnostic testing reliably diagnoses NF1 in 95% of cases.
- Patient interviews highlighted qualitative benefits of early, definitive diagnosis.
Conclusions:
- Implementing genetic testing for children with possible NF1 is a valuable health policy consideration.
- Genetic testing improves diagnostic accuracy and potentially reduces long-term healthcare costs.
- Earlier diagnosis through genetic testing offers significant patient benefits.
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...